×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MDWD – mediwound ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MDWD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
08:00 am
mdwd
MediWound to Report Third Quarter 2024 Financial Results
Low
Report
MediWound to Report Third Quarter 2024 Financial Results
10/27
09:36 am
mdwd
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year [Yahoo! Finance]
Low
Report
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year [Yahoo! Finance]
10/11
08:41 am
mdwd
MediWound Ltd. (NASDAQ: MDWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Low
Report
MediWound Ltd. (NASDAQ: MDWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
10/10
07:00 am
mdwd
MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
Low
Report
MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
10/8
08:00 am
mdwd
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
Neutral
Report
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
9/3
08:00 am
mdwd
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Date
Time
Symbol
Company Name
Action
%Chg
8/14/2024
07:00 am
mdwd
mediwound ltd. - ordinary shares
MISS
Report
-5.6%
mediwound ltd. - ordinary shares
5/29/2024
07:00 am
mdwd
mediwound ltd. - ordinary shares
MISS
Report
-10.3%
mediwound ltd. - ordinary shares
3/21/2024
07:00 am
mdwd
mediwound ltd. - ordinary shares
BEAT
Report
7.2%
mediwound ltd. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
07:55 pm
mdwd
Form SC 13G/A MediWound Ltd. Filed by: Point72 Asset Management, L.P.
Low
Report
Form SC 13G/A MediWound Ltd. Filed by: Point72 Asset Management, L.P.
11/14
04:07 pm
mdwd
Form 6-K MediWound Ltd. For: Nov 14
Low
Report
Form 6-K MediWound Ltd. For: Nov 14
10/23
02:58 pm
mdwd
Form SC 13G/A MediWound Ltd. Filed by: Rosalind Advisors, Inc.
Low
Report
Form SC 13G/A MediWound Ltd. Filed by: Rosalind Advisors, Inc.
10/1
08:24 am
mdwd
Form SC 13G MediWound Ltd. Filed by: Yelin Lapidot Holdings Management Ltd.
Medium
Report
Form SC 13G MediWound Ltd. Filed by: Yelin Lapidot Holdings Management Ltd.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/5
Mediwound Ltd (NASDAQ: MDWD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
12.0%
11/14 MediWound Reports Third Quarter 2019 Financial Results 7.7%
4/22 Mediwound Ltd (NASDAQ: MDWD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.1%
8/23 Form 6-K/A MediWound Ltd. For: Aug 23 4.3%
4/27 MediWound Strengthens Board of Directors 4.2%
6/6 Mediwound Ltd (NASDAQ: MDWD) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.0%
4/9 Mediwound Ltd (NASDAQ: MDWD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.0%
7/22 MediWound Launches EscharEx® U.S. Clinical Development Program 4.0%
7/16 MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds 2.9%
8/12 Form 6-K MediWound Ltd. For: Jun 30 2.3%
11/14 MediWound Reports Third Quarter 2019 Financial Results 7.7%
4/22 Mediwound Ltd (NASDAQ: MDWD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.1%
8/23 Form 6-K/A MediWound Ltd. For: Aug 23 4.3%
4/27 MediWound Strengthens Board of Directors 4.2%
6/6 Mediwound Ltd (NASDAQ: MDWD) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.0%
4/9 Mediwound Ltd (NASDAQ: MDWD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.0%
7/22 MediWound Launches EscharEx® U.S. Clinical Development Program 4.0%
7/16 MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds 2.9%
8/12 Form 6-K MediWound Ltd. For: Jun 30 2.3%
TOP News Decliners
5/7
Form 6-K MediWound Ltd. For: May 07
-19.0%
2/25 Form S-8 MediWound Ltd. -11.1%
2/25 Q4/2019 12/31/2019 EPS -0.130 ZacksConsensus -0.120 ActVsEst (0.010) - Miss -10.0%
8/14 Form 6-K MediWound Ltd. For: Aug 14 -9.0%
6/11 MediWound Appoints Mr. Boaz Gur-Lavie as Chief Financial Officer -6.7%
5/29 BARDA Upsizes Support for NexoBrid with an Additional $21 Million to Fund Continuous Access Treatment Protocol for Thermal Burn -4.2%
8/13 Q2/2019 6/30/2019 EPS -0.120 ZacksConsensus -0.150 ActVsEst 0.030 - Beat -3.9%
10/2 Form 6-K MediWound Ltd. For: Oct 02 -3.9%
5/21 Q1/2019 3/31/2019 EPS -0.150 ZacksConsensus -0.130 ActVsEst (0.020) - Miss -3.7%
3/30 MediWound Provides Corporate Update Related to COVID-19 Pandemic -3.6%
2/25 Form S-8 MediWound Ltd. -11.1%
2/25 Q4/2019 12/31/2019 EPS -0.130 ZacksConsensus -0.120 ActVsEst (0.010) - Miss -10.0%
8/14 Form 6-K MediWound Ltd. For: Aug 14 -9.0%
6/11 MediWound Appoints Mr. Boaz Gur-Lavie as Chief Financial Officer -6.7%
5/29 BARDA Upsizes Support for NexoBrid with an Additional $21 Million to Fund Continuous Access Treatment Protocol for Thermal Burn -4.2%
8/13 Q2/2019 6/30/2019 EPS -0.120 ZacksConsensus -0.150 ActVsEst 0.030 - Beat -3.9%
10/2 Form 6-K MediWound Ltd. For: Oct 02 -3.9%
5/21 Q1/2019 3/31/2019 EPS -0.150 ZacksConsensus -0.130 ActVsEst (0.020) - Miss -3.7%
3/30 MediWound Provides Corporate Update Related to COVID-19 Pandemic -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: